Details for 2018701574

Up to date per 03.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE KOMBINATION MIT EINEM ALK-INHIBITOR UND EINEM SP2-INHIBITOR

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018701574

EP Publication Number

3568204

E-Number

1604527

Language

PCT Number

IB18050111

Publication Date

20.11.2019 A

30.08.2023 B1

Registration Date

30.08.2023

AT Publication Date

15.09.2023

Application Date

08.01.2018

Registration Number

Priorities

10.01.2017

201762444493 P

IPC

A61K 31/4353 20060101AFI20230120BHEP

Maximum Duration of Protection

08.01.2038

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITAL55 Fruit Street Boston, MA 02114US

Representative

No representatives present

Inventor

DARDAEI ALGHALANDIS, Leilac/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

ENGELMAN, Jeffrey Adamc/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

HAO, Huaixiangc/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

LI, Fang181 Newport Street Arlington, Massachusetts 02476US

LAMARCHE, Matthew J.c/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

WANG, Hui-Qinc/o Novartis Institutes for Biomedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US